Home › Funds › Northwest & Ethical Investments L.P. › GILD

Northwest & Ethical Investments L.P. position in GILD

GILEAD SCIENCES INC · Health Care

Northwest & Ethical Investments L.P. reported holding 287,432 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$42.8M, representing 1.06% of its reported portfolio and ranking #17 among its reported holdings. Northwest & Ethical Investments L.P. has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)287.43K sh
Reported value held$42.84M
Portfolio Weight1.06%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Northwest & Ethical Investments L.P.'s GILD position evolved

Northwest & Ethical Investments L.P. first disclosed a stake in GILD in Q3 2023 at 232,848 shares (US$17.4M). The position peaked in Q1 2026 at 346,995 shares, worth US$48.4M. Across 13 filings, Northwest & Ethical Investments L.P. increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 287,432 shares valued at US$42.8M — a reduction of -7,253 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 232.85K $17.45M New
Q4 2023 238.99K $19.36M Add
Q1 2024 203.36K $14.90M Reduce
Q2 2024 202.83K $13.92M Hold
Q3 2024 234.57K $19.67M Add
Q4 2024 244.19K $22.56M Add
Q1 2025 284.81K $31.91M Add
Q2 2025 278.25K $30.85M Reduce
Q3 2025 318.82K $35.39M Add
Q4 2025 328.21K $40.29M Add
Q1 2026 347.00K $48.36M Add
Q2 2026 294.69K $37.23M Reduce
Q3 2026 287.43K $42.84M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Northwest & Ethical Investments L.P. held GILD?

Northwest & Ethical Investments L.P. has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Northwest & Ethical Investments L.P.'s current position in GILD?

As of Q3 2026, Northwest & Ethical Investments L.P. holds 287.43K shares of GILD (GILEAD SCIENCES INC), valued at $42.84M, representing 1.06% of its reported portfolio and ranking #17.

Has Northwest & Ethical Investments L.P. been buying or selling GILD?

In the latest 13F filing (Q3 2026), Northwest & Ethical Investments L.P. reduced its position in GILD. The position peaked in Q1 2026 at 347.00K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.